Inverse Relationship Between Clock Gene Expression and Inflammatory Markers in Ulcerative Colitis Patients Undergoing Remission
Background Changes in the expression of clock genes have been reported in inflammatory bowel disease (IBD) patients. Aims We aimed to investigate whether reduced inflammation restores clock gene expression to levels of healthy controls. Methods This was a prospective study. Participants completed qu...
Gespeichert in:
Veröffentlicht in: | Digestive diseases and sciences 2023-06, Vol.68 (6), p.2454-2462 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Changes in the expression of clock genes have been reported in inflammatory bowel disease (IBD) patients.
Aims
We aimed to investigate whether reduced inflammation restores clock gene expression to levels of healthy controls.
Methods
This was a prospective study. Participants completed questionnaires providing data on demographics, sleeping habits, and disease activity. Anthropometric parameters, C-reactive protein (CRP), and fecal calprotectin (Fcal) levels were collected. Peripheral blood samples were analyzed for clock gene (
CLOCK
,
BMAL1
,
CRY1
,
CRY2
,
PER1
,
PER2
) expression. Patients with IBD were separated by diagnosis into ulcerative colitis (UC) and Crohn’s disease (CD). Each diagnosis was further divided into active disease and disease under remission.
Results
Forty-nine patients with IBD and 19 healthy controls completed the study.
BMAL1
and
PER2
were significantly reduced in active patients with UC compared to patients with UC in remission.
BMAL1
,
PER1
, and
PER2
were significantly reduced in patients with UC with CRP > 5 mg/dl.
PER2
,
CRY1
, and
CRY2
were significantly reduced in patients with UC with Fcal > 250 mg/kg. Clock gene expression of patients with UC in remission was comparable to healthy controls. When all patients with IBD were analyzed, an overshoot in
CRY1
expression was observed in patients in remission, patients with CRP |
---|---|
ISSN: | 0163-2116 1573-2568 |
DOI: | 10.1007/s10620-023-07847-y |